Vnitr Lek 2006, 52(10):963-968

Subclinical thyropathies

K. Drbalová*, K. Herdová, P. Pačesová, M. Šimon
Endokrinologický ústav, Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc.

Subclinical thyreopathies are pathological states of the thyroid gland that show no corresponding clinical symptoms, yet may be detected sporadically by laboratory examination or screening methods. They represent a novel diagnostic entity (analogous to glucose tolerance impairment - IGT or impaired fasting glycemia - IFG), which appeared due to innovations in laboratory diagnostics (sensitive TSH detection methods) and recent focus on pre-clinical stages of manifestative diseases. From a wider point of view, subclinical thyreopathies include subclinical hypothyroidism, subclinical hyperthyrodism, thyroid volume or structure changes found accidentally by sonography, initial stages of malignancy - accidental detection of a micro-carcinoma and subclinical forms of thyroiditis. Controversy remains concerning exact definition, epidemiological issues, therapeutic intervention, evaluation of risk and gain implied in treatment of these borderline clinical stages and, last but not least, early screening of risk groups if necessary.

Keywords: subclinical hypothyroidism; subclinical hyperthyroidism; micro-carcinoma; subclinical thyroid gland inflammation

Received: June 26, 2006; Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drbalová K, Herdová K, Pačesová P, Šimon M. Subclinical thyropathies. Vnitr Lek. 2006;52(10):963-968.
Download citation

References

  1. Bauer DC, Ettinger B, Nevitt M et al. For the Study of Osteoporotic Fracture Research Group. Risk for fracture in women with low serum levels of thyroid stimulating hormone. Ann Inter Med 2001; 134: 561-568. Go to original source... Go to PubMed...
  2. Biondi B, Palmieri EA, Lombardi G et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904-914. Go to original source... Go to PubMed...
  3. Biondi B, Palmieri EA, Klain M et al. Subclinical hyperthyroidism: Clinical features and treatement options. Eurropean Journal of Endocronologists 2005; 152: 1-9. Go to original source... Go to PubMed...
  4. Canaris GJ, Manowitz NR, Mayor G et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-534. Go to original source... Go to PubMed...
  5. Casey BM, Dashe JS, Wells CE et al. Subclinical hypotyroidism and Pregnancy Outcomes. The American College of Obstetricians and Gynecologists 2005; 2: 239-245. Go to original source...
  6. Col NF, Surks MI, Daniels GH. Subclinical Thyroid Disease. JAMA 2004; 291: 239-243. Go to original source... Go to PubMed...
  7. Danese MD, Ladenson PW, Meinert CL et al. Effect of tyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative rewiew of literature. J Clin Endocrinol Metab 2000; 85: 2993-3001. Go to original source...
  8. Duntas LH. Subclinical thyroid disorders: The menace of Trojan horse. J Clin Invest 2003; 36: 472-480. Go to original source... Go to PubMed...
  9. Duntas LH. Thyroid Disease and Lipids. Thyroid 2002; 4: 287-293. Go to original source... Go to PubMed...
  10. Faber J, Jensen IW, Petersen L et al. Normalization of serum thyreotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopauzal women. Clin Endocrinol (Oxf) 1998; 48: 285-290. Go to original source... Go to PubMed...
  11. Fukata S, Kuma K, Sugawara M. Relationship between cigarettte smoking and hypothyroidism in patiens with Hashimotoű thyroiditis. J Endocrinol Investic 1996; 19: 607-612. Go to original source... Go to PubMed...
  12. Gharib H, Tuttle RM, Baskin HJ et al. Consensus Statement: Subclinical Thyroid Dysfunctiuon: A Joint Statement on Management from the American Association of Clinical Endocrinologist, the American Thyroid Association, and The Endocrine Society. J Clin Endocr Metab 2005; 90: 581-585. Go to original source... Go to PubMed...
  13. Haddow JE, Palomaki GE, Allan WC et al. Materna Thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555. Go to original source... Go to PubMed...
  14. Hollowell J, Staehling NW, Flanders WD et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to1994): National Health and Nutrition Examination Survey (NHANESIII). J Clin Endocrinol Metab 2002; 87: 489-499. Go to original source... Go to PubMed...
  15. Chadarevian R, Bruckert E, Leenhardt L et al. Components of the fibrinolytic system are differently altered in moderate and severe hypotyroidism. Clin Endocrinol Metab 2001; 86: 732-737. Go to original source... Go to PubMed...
  16. Kalmijn S, Mehta KM, Pols HAP et al. Subclinical hypertyroidism and the risk of dementi. The Rotterdam study. Clin Endocrinol (Oxf) 2000; 53: 733-737. Go to original source... Go to PubMed...
  17. Ladenson PW. Tyrotoxicosis and the heart: old and something new. J Clin Endocrin Metab 1993; 77: 332-333. Go to original source...
  18. Lekakis J, Papamichael C, Alevizaki M et al. Flow-mediated, endothelium-dependent vasodilatation is impaird in subjekt with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7: 411-414. Go to original source... Go to PubMed...
  19. Mayer O jr. Je subklinická hypotyreóza rizikovým faktorem kardiovaskulárních chorob? Cor Vasa 2004; 46: 123-127.
  20. Meier C, Strub JJ, Roth CB et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypoyroidism: a double blind, placebo controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001; 86: 4860-4866. Go to original source... Go to PubMed...
  21. Parle JV, Maisonneuve P, Sheppard MC. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001; 358: 861-865. Go to original source... Go to PubMed...
  22. Parle JV, Franklyn JA, Gross KW et al. Prevalence and folow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83. Go to original source... Go to PubMed...
  23. Pinchera A. Subclinical Thyroid Disease: To Treat Not To Treat? Thyroid 2005; 1: 1-2. Go to original source... Go to PubMed...
  24. Sawin CT, Geller A, Wolf PA et al. Low serum thyrotropin contrencation as a risk factor for atrial fibrilation in older person. N Engl J Med 1994; 331: 1249-1252. Go to original source... Go to PubMed...
  25. Surks MI, Oritz E, Daniels GH at al. Subclinical Thyroid Disease. JAMA 2004; 291: 228-238. Go to original source... Go to PubMed...
  26. Surks MI. Commentary: Subclinical Thyroid Dysfunctiuon: A Joint Statement on Management from the American Association of Clinical Endocrinologist, the American Thyroid Association, and The Endocrine Society. J Clin Endocr Metab 2005; 90: 586-587. Go to original source...
  27. Tauchmanova L, Nizzo V, Fonderico F et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas 2004; 3: 299-306. Go to original source...
  28. Vanderpump MP, Tunbridge WM, French JM et al. The development of ischemic heart disease in relation to autoimunite thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996; 6: 155-160. Go to PubMed...
  29. Zamrazil V. Subklinické tyreopatie. Interní medicína pro praxi 2004; 6: 295-299.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.